Bone remodelling: A signalling system for osteoclast regulation

Current Biology

Volumn 8, Issue 19, 1998, Pages

  Filvaroff, Ellen ^a   Derynck, Rik ^b  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032563896     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(98)70434-8     Document Type: Article

References (25)

1. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R: Toward a molecular understanding of skeletal development. Cell 1995, 80:371-378.
2. Reddi AH: Bone morphogenesis and modeling: soluble signals sculpt osteosomes in the solid state. Cell 1997, 89:159-161.
3. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okumura H, Sudo T, Shultz LD, Nishikawa S-I: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345:442-444.
4. Cecchini MG, Hofstetter W, Halasy J, Wetterwald A, Felix R: Role of CSF-1 in bone and bone marrow development. Mol Repr Dev 1997, 46:75-84.
5. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N: Modulation of osteoclast differentiation by local factors. Bone 1995, 17:87S-91S.
6. Heymann D, Guicheux J, Gouin F, Passuti N, Daculsi G: Cytokines, growth factors and osteoclasts. Cytokine 1998, 10:155-168.
7. Suda T, Nakamura I, Jimi E, Takahashi N: Regulation of osteoclast function. J Bone Min Res 1997, 12:869-879.
8. Chambers TJ, Owens JM, Hattersley G, Jat PS, Noble MD: Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci USA 1993, 90:5578-5582.
9. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al.: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
10. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997, 390:175-179.
11. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS III, Frankel WN, et al.: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997, 272:25190-25194.
12. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang C-P, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3:673-682.
13. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996, 271:12687-12690.
14. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S-I, Tomoyasu A, Yano K, Goto M, Murakami A, et al.: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998, 95:3597-3602.
15. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, et al.: Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 1998, 273:14363-14367.
16. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
17. Yasuda H, Shima N, Nakagawa N, Mochizuki S-I, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, et al.: Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998, 139:1329-1337.
18. Felix R, Hofstetter W, Cecchini MG: Recent developments in the understanding of the pathophysiology of osteopetrosis. Eur J Endocrinol 1996, 134:143-156.
19. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, et al.: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998, 12:1260-1268.
20. Banks LM, Macsweeney JE, Stevenson JC: Effect of degenerative spinal and aortic calcification on bone density measurements in postmenopausal women: links between osteoporosis and cardiovascular disease? Eur J Clin Invest 1994, 24:813-817.
21. Lewis DB, Liggitt HD, Effmann EL Motely ST, Teitelbaum SL, Jepsen KJ, Goldstein SA, Bonadio J, Carpenter J, Perlmutter RM: Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 1993, 90:11618-11622.
22. Takahashi T, Wada T, Mori M, Kokai Y, Ishii S: Overexpression of the granulocyte colony stimulating factor gene leads to osteoporosis in mice. Lab Invest 1996, 74:827-834.
23. Erlebacher A, Derynck R: Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 1996, 132:195-210.
24. Wong BR, Josien R, Lee SY, Sauter B, Li H-L, Steinman RM, Choi Y: TRANCE (tumor necrosis factor (TNF)-related activation induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997, 186:2075-2080.
25. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R: Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat Med 1997, 3:1285-1289.